derleme nary disease in 2010. Am J Respir Crit Care Med 2011;183(10):1311–5. 26. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009;5(3):e1000421. 27. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005;11(1):7–13. 28. Sin DD, Cohen SB, Day A, et al. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc 2007;4(8):671–4. 29. Vogelmeier CF, Wouters EF. Treating the systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011;8(4):376–9. 30. Lee SD, Ju G, Choi JA, et al. The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath 2011. 31. Lee R, McNicholas WT. Obstructive sleep apnea in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2011;17(2):79–83. 32. Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med 2005;26(2):142–53. 33. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350(26):2645–53. 34. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111(2):476–94. 35. Gosselink JV, Hayashi S, Elliott WM, et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(12):1329–35. 36. Mannino DM, Valvi D, Mullerova H, Tal-Singer R. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. COPD 2012; 9:359– 366. 37. Miniati M, Monti S, Bottai M, et al. Prognostic value of C-reactive protein in chronic obstructive pulmonary disease. Intern EmergMed 2011; 6:423–430 38. Cowburn AS, Condliffe AM, Farahi N, et al. Advances in neutrophil biology: clinical implications. Chest 2008; 134:606–61. 39. Nicholas BL, O’Connor CD, Djukanovic R. From proteomics to prescription –the search for COPD biomarkers. COPD 2009; 6:298–303. 40. Nicholas BL. Search for biomarkers in chronic obstructive pulmonary disease: current status. Curr Opin Pulm Med. <strong>2013</strong>;19(2):103-8. 41. Braber S, Thio M, Blokhuis BR, et al. An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:817–824. 42. Bonarius HP, Brandsma CA, Kerstjens HA, et al. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax 2011; 66:101– 107. 43. Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, et al. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir Med 2011; 105 (Suppl. 1):S31–S37. 44. Cappello F, Caramori G, Campanella C, et al. Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis. PLoS One 2011; 6:e28200. 45. Lindberg CA, Engstrom G, de Verdier MG, et al. Total desmosines in plasma and urine correlate with lung function. Eur Respir J 2012; 39:839–845. 46. Carter RI, Mumford RA, Treonze KM, et al. The fibrinogen cleavage product Aalpha-Val360, a specific marker of neutrophil elastase activity in vivo. Thorax 2011; 66:686–691. 47. Jouneau S, Khorasani N, DE Souza P, et al. EM- MPRIN (CD147) regulation of MMP-9 in bronchial epithelial cells in COPD. Respirology 2011; 16:705–712. 48. Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis. <strong>2013</strong> Jun;7(3):161-73. 49. Bush A. COPD: a pediatric disease. COPD. 2008;5(1):53-67. 50. Didon L, Roos AB, Elmberger GP, et al. Lung-specific inactivation of CCAAT/enhancer binding protein alpha causes a pathological pattern characteristic of COPD. Eur Respir J. 2010;35(1):186-97. 51. Narang I, Bush A. Early origins of chronic obstructive pulmonary disease. Semin Fetal Neonatal Med. 2012;17(2):112-8. 52. Dharmage SC, Erbas B, Jarvis D, et al. Do childhood respiratory infections continue to influence adult respiratory morbidity? Eur Respir J. 2009;33(2):237-44. 53. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010;65(1):14-20. 54. Gold DR, Tager IB, Weiss ST, et al. Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms. Am Rev Respir Dis. 1989;140(4):877-84. 55. Johnston ID, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med. 1998;338(9):581-7. 56. Castro-Rodríguez JA, Holberg CJ, Wright AL, Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med. 1999;159(6):1891-7. 12
57. Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet. 2007;370(9589):758-64. 58. Tujague J, Bastaki M, Holland N et al. Antioxidant intake, GSTM1 polymorphism and pulmonary function in healthy young adults. Eur Respir J. 2006;27(2):282-8. 59. Barragán-Meijueiro MM, Morfín-Maciel B, Nava-Ocampo AA. A Mexican population-based study on exposure to paracetamol and the risk of wheezing, rhinitis, and eeczema in childhood. J Investig Allergol Clin Immunol. 2006;16(4):247-52. 60. Jedrychowski W, Maugeri U, Jedrychowska-Bianchi I, et al. Effect of indoor air quality in the postnatal period on lung function in pre-adolescent children: a retrospective cohort study in Poland. Public Health. 2005;119(6):535-41. 13
Change language